Matthew Shawn Morris - 26 Feb 2026 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Director
Signature
/s/ Anita Beth Adams, as attorney-in-fact
Issuer symbol
PRVA
Transactions as of
26 Feb 2026
Net transactions value
-$559,696
Form type
4
Filing time
02 Mar 2026, 17:23:20 UTC
Previous filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morris Matthew Shawn Director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON /s/ Anita Beth Adams, as attorney-in-fact 02 Mar 2026 0001401958

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, par value $0.01 per share Options Exercise $15,576 +7,788 +11% $2.00 75,976 26 Feb 2026 Direct F1
transaction PRVA Common Stock, par value $0.01 per share Sale $194,622 -7,788 -10% $24.99 68,188 26 Feb 2026 Direct F1, F2
transaction PRVA Common Stock, par value $0.01 per share Options Exercise $33,100 +16,550 +24% $2.00 84,738 27 Feb 2026 Direct F1
transaction PRVA Common Stock, par value $0.01 per share Sale $413,750 -16,550 -20% $25.00 68,188 27 Feb 2026 Direct F1, F3
holding PRVA Common Stock, par value $0.01 per share 11,998 26 Feb 2026 By Trust
holding PRVA Common Stock, par value $0.01 per share 12,487 26 Feb 2026 By Emerald Family, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -7,788 -0.21% $0.000000 3,708,864 26 Feb 2026 Common Stock, par value $0.01 per share 7,788 $2.00 Direct F1, F4
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -16,550 -0.45% $0.000000 3,692,314 27 Feb 2026 Common Stock, par value $0.01 per share 16,550 $2.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.13 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.15 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 All of the stock options are fully vested and exercisable.